Research Article | Open Access
Pradeep H. Lakshminarayana, Adiba A. Geeti, Umer M. Darr, David A. Kaufman, "Can Transcutaneous CO2 Tension Be Used to Calculate Ventilatory Dead Space? A Pilot Study", Critical Care Research and Practice, vol. 2016, Article ID 9874150, 4 pages, 2016. https://doi.org/10.1155/2016/9874150
Can Transcutaneous CO2 Tension Be Used to Calculate Ventilatory Dead Space? A Pilot Study
Dead space fraction () measurement performed using volumetric capnography requires arterial blood gas (ABG) sampling to estimate the partial pressure of carbon dioxide (). In recent years, transcutaneous capnography () has emerged as a noninvasive method of estimating . We hypothesized that CO2 can be used as a substitute for in the calculation of . In this prospective pilot comparison study, 30 consecutive postcardiac surgery mechanically ventilated patients had calculated separately using volumetric capnography by substituting CO2 for . The mean calculated using and CO2 was 0.48 ± 0.09 and 0.53 ± 0.08, respectively, with a strong positive correlation between the two methods of calculation (Pearson’s correlation = 0.87, ). Bland-Altman analysis showed a mean difference of −0.05 (95% CI: −0.01 to −0.09) between the two methods. CO2 measurements can provide a noninvasive means to measure , thus accessing important physiologic information and prognostic assessment in patients receiving mechanical ventilation.
The ventilatory dead space fraction () is defined as the portion of tidal volume that does not participate in gas exchange because it does not reach perfused lung units. Clinically, may be measured using volumetric capnography and the Enghoff modification of the Bohr equation, which stateswhere is the partial pressure of carbon dioxide in the arterial blood and CO2 is the partial pressure of carbon dioxide in exhaled air . may increase in a variety of pathological situations, especially conditions with obstruction of the pulmonary vasculature . Measuring requires arterial blood gas (ABG) sampling to measure . Transcutaneous capnography (CO2) has emerged as a noninvasive method of estimating . The objective of our study was to evaluate the relationship between CO2 and in calculating . We hypothesized that CO2 can be used as a substitute for in the calculation of .
This was a prospective pilot comparison study conducted at a single 383-bed urban, community-teaching hospital. We recruited thirty consecutive adult patients admitted to the Surgical Intensive Care Unit (SICU) after cardiac surgery from May 1, 2014, until December 1, 2014. We excluded patients who were extubated within 4 hours of arrival to the SICU. The Bridgeport Hospital Institutional Review Board (IRB) approved this study.
Volumetric capnography was performed within 12 hours of patient arrival to the SICU. A CAPNOSTAT® CO2 sensor was attached between the subject’s endotracheal tube and the Y-piece of the ventilator circuit to obtain breath-by-breath volumetric capnography using NICO2 volumetric capnography (Philips-Respironics®, Wallingford, CT). We measured CO2 using the Tosca 500 (Radiometer®, Copenhagen, Denmark), according to the manufacturer’s instructions. A fully automated calibration of the transcutaneous CO2 sensor (Tosca sensor 92) containing a Stow-Severinghaus type electrode was performed using CAL-Gas (Radiometer), which contained 12% O2, 7% CO2, and 81% N2 prior to each monitoring period and every time the membrane of the transcutaneous sensor was changed (every 14 days). First, the sensor probe and the subject’s earlobe were cleaned with alcohol and dried prior to each measurement. Then, the sensor was placed on the earlobe after placing a drop of contact solution provided by the manufacturer and secured by means of an adhesive clip. No CO2 values were collected until the ear lobe reached an appropriate temperature of 42°C and stable signals for both CO2 and CO2 were achieved after at least 15 minutes. The CO2 was recorded at the same time an arterial blood sample was collected from an existing radial arterial line, placed on ice, and sent immediately for standard blood gas analysis. was measured using the arterial blood gas sample analyzed with Cobas b221 blood gas analyzer (Roche®). Turnaround time for the result was under 10 minutes for all samples. We calculated using both simultaneously measured values for and CO2 using NICO2 volumetric capnography according to the manufacturer’s instructions. In this study, we used single measurements of CO2, , and CO2 to calculate , with all values obtained simultaneously. The calculated using was considered the reference standard .
2.1. Statistical Analysis
Statistical analysis was performed using SPSS version 9.0. Results from descriptive statistics are presented as mean ± standard deviation (SD). Linear regression and Bland-Altman analyses were performed to compare the values of using CO2 and measurements.
30 consecutive postcardiac surgery patients were included and 30 separate volumetric capnography measurements were obtained. Statistical description of the study population can be found in Table 1. 24 patients were males, mean age was 68.25 ± 6.36 years, and the mean Acute Physiology and Chronic Health Evaluation (APACHE) II score was 14.5 ± 3.92. The mean calculated using and CO2 was 0.48 ± 0.09 and 0.53 ± 0.08, respectively, with a strong positive correlation between the two methods of calculation (Pearson’s correlation = 0.87, ) as shown in Figure 1. Bland-Altman analysis showed a mean difference of −0.05 (95% CI: −0.01 to −0.09) between the two methods of measurements as shown in Figure 2.
|Patients may have more than one comorbidity.|
Miscellaneous comorbidities included cirrhosis, chronic kidney disease, HIV and malignancy.
All patients maintained on volume assist control mode of mechanical ventilation.
Measured only in 27 patients who had a pulmonary artery catheter.
Abbreviations: CABG: coronary artery bypass graft; APACHE: acute physiology and chronic health evaluation.
Measuring at the bedside can be easily performed with volumetric capnography, in which both exhaled tidal volume and CO2 are measured. The CO2 is compared to determined from the arterial blood, and the Enghoff modification of the Bohr equation is used to calculate . has been shown to be useful in identifying cardiac surgery patients with microthrombosis of the pulmonary circulation  and ARDS patients who have an increased risk for death . It has also been proposed to help identify patients with pulmonary embolism  and to risk-stratify intubated patients for extubation failure . A drawback of this method is that it requires sampling of the arterial blood, which can be painful and may cause complications. Thus, a noninvasive test to estimate might be helpful.
A transcutaneous measurement of CO2 is based on the principle that an increase in skin capillary blood flow facilitates diffusion of CO2, hence allowing its detection by a sensor located at the skin surface. The sensor is also equipped with a thermostatically controlled heater unit, which allows an increase in temperature of the skin surface. The Stove-Severinghaus type CO2 sensor is a potentiometric sensor combining a silver/silver chloride reference electrode and a miniature glass pH electrode. CO2 is determined by a change in pH of the electrolyte solution [4, 10].
CO2 is a noninvasive method of estimating used frequently in clinical practice. Its application has been widely noted during mechanical ventilation, anesthesia, bronchoscopy, and sleep studies . Whether substituting CO2 for yields accurate measurements of is unreported in the scientific literature. We performed a prospective pilot comparison to explore whether using CO2 in place of in the Enghoff-Bohr calculation would yield accurate estimates of . Our observations show a strong positive correlation between both methods of estimating with good agreement between the two techniques.
Our study has some limitations. First, the sample size is small. We consider our findings to be preliminary. They will require confirmation in a larger cohort of patients. Second, we conducted our study exclusively in patients who had undergone cardiac surgery, both emergent and elective. We chose this group because it is relatively homogeneous with regard to complicating respiratory and metabolic disorders, thereby minimizing residual confounders that might bias the results. Whether our findings can be extrapolated to other critically ill populations will require further investigation. For example, it is plausible that transcutaneous CO2 measurements will be less accurate in patients with circulatory failure or shock, as peripheral blood flow may be diminished. Finally, our goal was limited. We sought to test how well calculations using CO2 measurements compared to calculations using . We did not employ a reference standard measurement of such as mixed inert gas elimination technique, as such techniques are found only in highly specialized research centers. It is possible that unmeasured confounders that affect volumetric capnography might result in random or systematic biases that make our findings unreliable. Indeed, CO2 could be influenced by advanced age, hypothermia, hypercapnia, and use of vasopressor and inotropic support. A larger observational study would be essential to determine the influence of these potential confounders on measurement. Nonetheless, we believe that our methods represent a real-world approach to use bedside measurements and that CO2 may be an acceptable substitute for to calculate .
Thus, we propose that substituting CO2 for CO2 may be clinically useful and provide a noninvasive means for estimating . Using a noninvasive CO2 measurement to calculate potentially could permit more frequent estimates of when multiple samples of arterial blood are unavailable or invasive procedures are not desired. For example, it is plausible that following the over the course of a spontaneous breathing trial could be useful at identifying patients at high risk for requiring continued mechanical ventilator support, as has been shown in pediatric patients with respiratory failure . Future work incorporating noninvasive CO2 measurements into calculations should focus on whether these estimates are valid in a broader population of critically ill patients and whether measurements can be incorporated into treatment strategies to yield improved patient-centered outcomes.
CO2 may be a useful substitute for CO2 to calculate the dead space fraction. CO2 measurements can provide a noninvasive means to measure the dead space fraction, thus allowing us to obtain important physiologic information and prognostic assessment in critically ill patients on mechanical ventilation.
The authors declare that they have no competing interests.
- P. Sinha, O. Flower, and N. Soni, “Deadspace ventilation: a waste of breath!,” Intensive Care Medicine, vol. 37, no. 5, pp. 735–746, 2011.
- L. Blanch, P. V. Romero, and U. Lucangelo, “Volumetric capnography in the mechanically ventilated patient,” Minerva Anestesiologica, vol. 72, no. 6, pp. 577–585, 2006.
- G. Tusman, F. S. Sipmann, and S. H. Bohm, “Rationale of dead space measurement by volumetric capnography,” Anesthesia & Analgesia, vol. 114, no. 4, pp. 866–874, 2012.
- P. Eberhard, “The design, use, and results of transcutaneous carbon dioxide analysis: current and future directions,” Anesthesia & Analgesia, vol. 105, no. 6, pp. S48–S52, 2007.
- F. Suarez-Sipmann, A. Santos, S. H. Böhm, J. B. Borges, G. Hedenstierna, and G. Tusman, “Corrections of Enghoff's dead space formula for shunt effects still overestimate Bohr's dead space,” Respiratory Physiology and Neurobiology, vol. 189, no. 1, pp. 99–105, 2013.
- B. Dixon, D. J. Campbell, and J. D. Santamaria, “Elevated pulmonary dead space and coagulation abnormalities suggest lung microvascular thrombosis in patients undergoing cardiac surgery,” Intensive Care Medicine, vol. 34, no. 7, pp. 1216–1223, 2008.
- T. J. Nuckton, J. A. Alonso, R. H. Kallet et al., “Pulmonary dead-space fraction as a risk factor for death in the acute respiratory distress syndrome,” The New England Journal of Medicine, vol. 346, no. 17, pp. 1281–1286, 2002.
- J. A. Kline, S. Meek, D. Boudrow, D. Warner, and S. Colucciello, “Use of the alveolar dead space fraction (Vd/Vt) and plasma D-dimers to exclude acute pulmonary embolism in ambulatory patients,” Academic Emergency Medicine, vol. 4, no. 9, pp. 856–863, 1997.
- A. González-Castro, V. Suárez-Lopez, V. Gómez-Marcos et al., “Utility of the dead space fraction (Vd/Vt) as a predictor of extubation success,” Medicina Intensiva, vol. 35, no. 9, pp. 529–538, 2011.
- S. A. Rubortone, M. P. De Carolis, S. Lacerenza, I. Bersani, F. Occhipinti, and C. Romagnoli, “Use of a combined SpO2/PtcCO2 sensor in the delivery room,” Sensors, vol. 12, no. 8, pp. 10980–10989, 2012.
- C. L. Hubble, M. A. Gentile, D. S. Tripp, D. M. Craig, J. N. Meliones, and I. M. Cheifetz, “Deadspace to tidal volume ratio predicts successful extubation in infants and children,” Critical Care Medicine, vol. 28, no. 6, pp. 2034–2040, 2000.
Copyright © 2016 Pradeep H. Lakshminarayana et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.